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ADP-ribosyltransferases (ADP-RTs) are a family of
enzymes secreted by pathogenic bacteria. They catalyse
the hydrolysis of NAD+ and the transfer of the ADP-
ribosyl group onto specific target proteins [1,2]. Figure 1
Although ADP-RTs are important drug targets, only
few inhibitors are known so far. The high selectivity of
these inhibitors suggest different mechanism of binding
to the ADP-RTs active sites. To explain the structural
differences, we started a systematic program towards the
development of new ADP-RT inhibitors. This is based
on multiple virtual screening experiments (e.g. docking,
pharmacophore searching and binding free-energy cal-
culations) and the development of an in vitro assay for
ADP-RTs. Active compounds identified in the first
screening round are the basis for further in silico studies
and optimisation steps. The aim of the current work is
the discovery of novel drug-leads and the formulation of
structure-function relationships which can explain the
selectivity of ligand binding to the NAD+ pocket. This
is interesting from a drug discovery perspective, as
many enzymes utilizing NAD+ are valid or potential
drug targets.
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